Abstract
This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.
| Original language | English |
|---|---|
| Place of Publication | London |
| Publisher | Palgrave Macmillan |
| Number of pages | 240 |
| Edition | 1 |
| ISBN (Electronic) | 9781137430526 |
| ISBN (Print) | 9781137436283, 9781349576678 |
| DOIs | |
| Publication status | Published - 18 Nov 2015 |
Keywords / Materials (for Non-textual outputs)
- bioeconomy
- innovation ecosystem
- value
- values
- new biology
- life sciences
- governance
- regulation
- health
- R&D
- bioindustry
- pharmaceuticals
- therapy
- expectations
- public-private partnerships
- collaboration
- reimbursement
- technology assessment
- interdisciplinary
Fingerprint
Dive into the research topics of 'The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-First Century'. Together they form a unique fingerprint.Profiles
-
James Mittra
- School of Social and Political Science - Personal Chair of Science, Technology and Innovation Studies
- Global Health Academy
- Innogen Institute
Person: Academic: Research Active